P Tabarsi

Summary

Affiliation: National Research Institute of Tuberculosis and Lung Disease
Country: Iran

Publications

  1. pmc Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran
    Masoud Mardani
    Iranian Infectious Disease Research Center, Shaheed Beheshti Medical University, Tehran, Iran
    Ann Thorac Med 5:43-6. 2010
  2. pmc Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients
    P Tabarsi
    Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J STD AIDS 23:e1-4. 2012
  3. ncbi Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients
    Payam Tabarsi
    Transplantation Research Center, National Research Institute for Tuberculosis and Lung Disease, Massih Daneshvari Hospital, Shaheed Beheshti University of Medical Science, Tehran, Iran
    Exp Clin Transplant 10:278-81. 2012
  4. doi Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study
    Payam Tabarsi
    Mycobacteriology Research Centre, N R I T L D, Shaheed Beheshti Medical University, Tehran, Iran
    Scand J Infect Dis 41:10-3. 2009
  5. ncbi Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria
    Payam Tabarsi
    Masih Daneshvari Hospital, Darabad, Tehran, Iran
    Am J Med Sci 337:182-4. 2009
  6. ncbi Lymphocytic bronchiolitis as presenting disorder in an undiagnosed adult patient with chronic granulomatous disease
    Payam Tabarsi
    National Research Institute of TB and Lung disease, Niavaran Darabad, Massih Daneshvari Hospital, Tehran, Iran
    Iran J Allergy Asthma Immunol 6:219-21. 2007
  7. ncbi Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran
    Payam Tabarsi
    Mycobacteriology Research Center, NRITLD Massih Daneshvari Hospital, Darabad, Niavaran, Tehran, Iran
    Saudi Med J 29:148-50. 2008
  8. doi Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran
    Payam Tabarsi
    Mycobacteriology Research Center, NRITLD, Shaheed Beheshti, University of Medical Sciences, Tehran, Iran
    Respirology 13:108-11. 2008
  9. ncbi Clinical and laboratory profile of patients with tuberculosis/HIV coinfection at a national referral centre: a case series
    P Tabarsi
    National Research Institute of Tuberculosis and Lung Disease, Tehran, Islamic Republic of Iran
    East Mediterr Health J 14:283-91. 2008
  10. ncbi Multi-drug resistant tuberculosis in pregnancy: need for more intensive treatment
    P Tabarsi
    Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
    Infection 35:477-8. 2007

Collaborators

  • P Farnia
  • Parvaneh Baghaei
  • M Amiri
  • Masoud Shamaei
  • S Karimi
  • S M Mirsaeidi
  • Frederick L Altice
  • Reza Majdzadeh
  • Ja Caminero
  • K Najafizadeh
  • Soheila Khalilzadeh
  • Fanak Fahimi
  • Masoud Mardani
  • B Sharif-Kashani
  • Kaveh Khoshnood
  • H Heidarnazhad
  • Massoud Houshmand
  • Davood Mansouri
  • Ali Akbar Velayati
  • M Marjani
  • M R Masjedi
  • Mohammad R Masjedi
  • Ali A Velayati
  • Mohammad Reza Masjedi
  • D Mansouri
  • Nahal Mansouri
  • Shadi Baniasadi
  • M B Shadmehr
  • Mohammad Abbasi Nazari
  • A Abbasi
  • A A Velayati
  • Mehdi S Mirsaeidi
  • Mehdi Seyed Mirsaeidi
  • Golnaz Ebrahimi
  • Farah Dokht Fateminasab
  • Saeed F Tafti
  • Mehdi Mirsaeidi
  • Parisa Adimi
  • A Velayati
  • Parivash Eftekhari
  • Ehsan Chitsaz
  • Mohammad Reza Raoufy
  • Sara Jalali
  • Rafiuz Zaman Haroun
  • Farzad Kobarfard
  • S Dabir
  • M Arab
  • T Parsa
  • Z H Ahmadi
  • B Sharif Kashani
  • Abol Hassan Ziazarifi
  • Jamshid Salamzadeh
  • F Ghorbani
  • Abdul Rahman Omar
  • Ali Naghee Kabarei
  • F Mohammadi
  • Ho Oi Kuan
  • Jalladein Ghanavi
  • Tengku Azmi Ibrahim
  • Sven Eric Hoffner
  • A Daneshvar
  • Mohammad Varahram
  • N Javaherzadeh
  • S Pejhan
  • S D Mansoori
  • Jalaledin Ghanavi
  • S Shafaghi
  • B Radpay
  • S Motahari
  • E Chitsaz
  • P Javanmard
  • F Rashid Farokhi
  • B Sharifkashani
  • M Mirsaeidi
  • Omid Radpour
  • Zarnaz Bagheri
  • Ali Rowhani-Rahbar
  • Matthew W Morris
  • Mohamad A Motazedi Ghajar
  • Shapour Shahgasempour
  • Seyed Davood Mansoori
  • Hossain M Najar
  • Zinat Entezami
  • Guillaume Vogt
  • Jacinta Bustamante
  • Soheila Zahirifard
  • Mohammad Naderi
  • Ali Cheraghvandi
  • Ludovic de Beaucoudrey
  • Reza Rouhi

Detail Information

Publications45

  1. pmc Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran
    Masoud Mardani
    Iranian Infectious Disease Research Center, Shaheed Beheshti Medical University, Tehran, Iran
    Ann Thorac Med 5:43-6. 2010
    ..We intended to determine the performance of QFT-G compared to conventional tuberculin skin test (TST) in detecting LTBI in HIV-positive individuals in Iran...
  2. pmc Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients
    P Tabarsi
    Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J STD AIDS 23:e1-4. 2012
    ..05). Administration of cART led to significantly better outcomes (P < 0.001). Lower serum albumin levels and low body weight were significantly associated with mortality...
  3. ncbi Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients
    Payam Tabarsi
    Transplantation Research Center, National Research Institute for Tuberculosis and Lung Disease, Massih Daneshvari Hospital, Shaheed Beheshti University of Medical Science, Tehran, Iran
    Exp Clin Transplant 10:278-81. 2012
    ..This study sought to compare the sensitivities of serum galactomannan and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients (lung and heart)...
  4. doi Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study
    Payam Tabarsi
    Mycobacteriology Research Centre, N R I T L D, Shaheed Beheshti Medical University, Tehran, Iran
    Scand J Infect Dis 41:10-3. 2009
    ..Follow-up studies on a long-term basis are however needed in order to detect possible relapses...
  5. ncbi Nontuberculous mycobacteria among patients who are suspected for multidrug-resistant tuberculosis-need for earlier identification of nontuberculosis mycobacteria
    Payam Tabarsi
    Masih Daneshvari Hospital, Darabad, Tehran, Iran
    Am J Med Sci 337:182-4. 2009
    ..In this study, we intended to find the prevalence of nontuberculosis mycobacteria (NTM) among patients who are referred as suspected multidrug-resistant tuberculosis (MDR-TB) cases to the only referral center in Iran...
  6. ncbi Lymphocytic bronchiolitis as presenting disorder in an undiagnosed adult patient with chronic granulomatous disease
    Payam Tabarsi
    National Research Institute of TB and Lung disease, Niavaran Darabad, Massih Daneshvari Hospital, Tehran, Iran
    Iran J Allergy Asthma Immunol 6:219-21. 2007
    ....
  7. ncbi Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran
    Payam Tabarsi
    Mycobacteriology Research Center, NRITLD Massih Daneshvari Hospital, Darabad, Niavaran, Tehran, Iran
    Saudi Med J 29:148-50. 2008
  8. doi Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran
    Payam Tabarsi
    Mycobacteriology Research Center, NRITLD, Shaheed Beheshti, University of Medical Sciences, Tehran, Iran
    Respirology 13:108-11. 2008
    ..This study investigated patients suspected to have MDR-TB, attending the TB referral hospital in Iran...
  9. ncbi Clinical and laboratory profile of patients with tuberculosis/HIV coinfection at a national referral centre: a case series
    P Tabarsi
    National Research Institute of Tuberculosis and Lung Disease, Tehran, Islamic Republic of Iran
    East Mediterr Health J 14:283-91. 2008
    ..Drug-induced hepatitis occurred in 3 patients and 12 had hepatitis C coinfection. Five patients died. The mean CD4 count was 229.2 (SD 199.5) cells/mm3 and 78.6% had CD4 count < 350. TB may be an AIDS-defining illness in this country...
  10. ncbi Multi-drug resistant tuberculosis in pregnancy: need for more intensive treatment
    P Tabarsi
    Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
    Infection 35:477-8. 2007
  11. pmc Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV
    Payam Tabarsi
    Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Science, Tehran, Iran
    J Int AIDS Soc 12:14. 2009
    ..abstract:..
  12. doi Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases
    Payam Tabarsi
    Mycobacteriology Research Center, NRITLD, Sheheed, Beheshti University of Medical Science, Tehran, Iran
    Am J Ther 18:343-9. 2011
    ..This strategy significantly reduces delays to MDR TB diagnosis and to the initiation of MDR TB therapy. Success rate of this strategy is 62.2% and 72% in MDR TB and overall CAT I failure cases and defaulters, respectively...
  13. doi Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran
    Payam Tabarsi
    Mycobacteriology Research Center, NRITLD, Shaheed Beheshti University of Medical Science, Tehran, Iran
    Microb Drug Resist 16:81-6. 2010
    ..In this setting, a standardized second-line drugs regimen produces high treatment success rates in MDR-TB patients unless XDR-TB is present...
  14. ncbi Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis
    P Tabarsi
    Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Shaheed Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
    East Mediterr Health J 15:1346-50. 2009
    ..8%) patients were cured, 4 (15.4%) resulted in treatment failure, and 1 (3.8%) died. In the modified treatment group, 16 (100%) patients were cured, These differences were not statistically significantly different (P = 0.194)...
  15. ncbi First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran
    P Tabarsi
    Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J STD AIDS 20:566-70. 2009
    ..8%), rifampin (9.2%) and ethambutol (3%). Drug resistance to antitubercular agents in TB-HIV co-infected patients in Iran is high compared with other reports. Drug resistance is higher among those who have had prior anti-TB medication...
  16. doi Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis
    M Shamaei
    Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari University Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J STD AIDS 20:320-3. 2009
    ..Moreover, the manifestations of the disease should be considered seriously regardless of attributing them to drug use...
  17. ncbi Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006
    M R Masjedi
    Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J Tuberc Lung Dis 12:750-5. 2008
    ..There is still no consensus on the subject, with controversies regarding treatment protocols, treatment outcomes and the various treatment regimens...
  18. ncbi Primary multi-drug resistant tuberculosis presented as lymphadenitis in a patient without HIV infection
    S M Mirsaeidi
    National Research Institute of Tuberculosis and Lung Diseases, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
    Monaldi Arch Chest Dis 61:244-7. 2004
    ..By increasing the number of drug resistant tuberculosis patients around the world, appropriate diagnosis and treatment of different presentations of the disease need a special attention...
  19. ncbi Perianal tuberculosis in an HIV-positive patient
    P Tabarsi
    Department of Tuberculosis and HIV AIDS, National Research Institute of Tuberculosis and Lung Diseases, Tehran, Islamic Republic of Iran
    East Mediterr Health J 12:923-6. 2006
  20. doi Standardised second-line treatment of multidrug-resistant tuberculosis during pregnancy
    P Tabarsi
    Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Diseases, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J Tuberc Lung Dis 15:547-50. 2011
    ..No adverse effects were observed in mothers or neonates. The treatment of MDR-TB during pregnancy with a standardised second-line regimen in this study population was safe, with an acceptable rate of treatment success...
  21. doi Pulmonary aspergillosis in solid organ transplant patients: a report from Iran
    M Marjani
    Transplant Research Center, Massih Daneshvari Hospital, Darabad Niavaran, Tehran, Iran
    Transplant Proc 40:3663-7. 2008
    ..Aspergillosis is one of the most important opportunistic infections after organ transplantation. Early diagnosis and initiation of appropriate antifungal therapy are key factors for better prognosis...
  22. ncbi Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis
    M Marjani
    Clinical Tuberculosis and Epidemiology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran
    East Mediterr Health J 18:957-61. 2012
    ..Due to the low frequency of multi-drug resistance in the recurrent cases, a CAT I regimen may be suitable for empirical therapy before drug sensitivity results become available...
  23. ncbi Lack of association between interferon-gamma receptor-1 polymorphism and pulmonary TB in Iranian population sample
    S M Mirsaeidi
    National Research Institute of Tuberculosis and Lung Disease, Tehran, Iran
    J Infect 52:374-7. 2006
    ..Tuberculosis is one of the most common infectious diseases in the world. In recent years, genetically approach has been developed. One of the interesting gene for investigator is IFN-gammaR1...
  24. doi Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran
    Ali Akbar Velayati
    Mycobacteriology Research Centre, the National Research Institute of Tuberculosis and Lung Disease, World Health Organization Collaborating Centre, Shahid Beheshti University, Darabad, Tehran, Iran
    Chest 136:420-5. 2009
    ..The study documented the emergence of new forms of resistant bacilli (totally drug-resistant [TDR] or super extensively drug-resistant [XDR] tuberculosis [TB] strains) among patients with multidrug-resistant TB (MDR-TB)...
  25. ncbi Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis
    F Fahimi
    Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases, Masih Daneshvari Hospital, Tehran, Iran Clinical Pharmacy Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J Tuberc Lung Dis 17:1602-6. 2013
    ..Low concentrations of anti-tuberculosis drugs are related to drug resistance and treatment failure...
  26. ncbi Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran
    Mehdi S Mirsaeidi
    Department of Infectious Disease and Clinical Immunology, National Research Institute of Tuberculosis and Lung Disease, Shaheed Beheshti Medical Science University, Tehran, Iran
    Saudi Med J 28:544-50. 2007
    ..To determine the drug resistance pattern to first line antituberculous drugs in National Research Institute of Tuberculosis and Lung Disease and to compare resistant rates with previous studies...
  27. ncbi Impact of chronic renal failure on anti-tuberculosis treatment outcomes
    P Baghaei
    Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Int J Tuberc Lung Dis 18:352-6. 2014
    ..National Referral Centre for Tuberculosis (TB), Tehran, Iran...
  28. doi Eight years of lung transplantation: experience of the National Research Institute of Tuberculosis and Lung Diseases
    M B Shadmehr
    National Research Institute of Tuberculosis and Lung Diseases, Massih Daneshvari Hospital, Tehran, Iran
    Transplant Proc 41:2887-9. 2009
    ..In Iran, the first single-lung transplantation was performed in the year 2000, more than 3 decades after the first successful procedure in the world, and the first double-lung transplantation was performed in the year 2006...
  29. doi Bilateral diffuse pulmonary infiltration in a heart transplant recipient
    B Sharif-Kashani
    Cardiovascular Department, Masih Daneshvari Hospital, Shahid Beheshti University MC, Tehran, Iran
    Transpl Infect Dis 12:258-60. 2010
    ..Following modulation of the immunosuppressive regimen and addition of chemotherapy, the patient had an excellent response and has had an uneventful 1-year follow-up...
  30. ncbi Pulmonary mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor?
    S M Mirsaeidi
    National Research Institute of Tuberculosis and Lung Disease, Shaheed Beheshti University of Medical Science, Tehran, Iran
    Monaldi Arch Chest Dis 65:106-9. 2006
    ..We propose that in patients with the HTLV infection and pulmonary symptoms and signs compatible with tuberculosis, evaluation for atypical mycobacteriosis may be recommendable...
  31. doi Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity
    Shadi Baniasadi
    Pharmaceutical Care Department, Virology Research Center, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
    Eur J Gastroenterol Hepatol 22:1235-8. 2010
    ..Isoniazid, rifampicin, and pyrazinamide, the first-line antituberculosis (anti-TB) drugs, are associated with hepatotoxicity...
  32. pmc The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping
    Parissa Farnia
    Mycobacteriology Research Centre, Iranian National Reference TB Laboratory, National Research Institute of Tuberculosis and Lung Disease, Shaheed Bahesti University of Medical Sciences Medical Campus, Darabad, Tehran, Iran
    BMC Infect Dis 8:109. 2008
    ..This survey evaluated the rate of reactivation versus recent transmission among Iranian and Afghan relapse cases...
  33. doi Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases
    Parvaneh Baghaei
    Tuberculosis Department, Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    Am J Ther 17:17-22. 2010
    ..Our study indicated that DIH most often occurs during the first 2 weeks of anti-TB treatment. DIH development is associated with old age, certain clinical manifestations, and higher death rates...
  34. doi First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance
    Masoud Shamaei
    Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari University Hospital, Shahid Beheshti University of Medical Sciences, Darabad, Niavaran Sq, Tehran, 1955841452, Iran
    Int J Infect Dis 13:e236-40. 2009
    ..Resistance to anti-tuberculosis (anti-TB) drugs is becoming a major and alarming threat in most regions worldwide...
  35. ncbi Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran
    Seyed Mehdi Mirsaeidi
    Department of Tuberculosis and Respiratory Infections, Iranian National Research Institute of Tuberculosis and Lung Diseases, Tehran 19556, Iran
    Int J Infect Dis 9:317-22. 2005
    ..Masih Daneshvari Hospital, Tehran, Iran, 2000-2002...
  36. doi Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients
    Mohammad R Masjedi
    Department of TB and Respiratory Infection, National Research Institute of TB and Lung disease, Masih Daneshvari Hospital, Niavaran Darabad, Tehran, Iran
    Int J Infect Dis 14:e399-402. 2010
    ..XDR-TB poses a risk of higher failure rates and death during TB treatment. We report herein the outcomes of XDR-TB in patients treated with the standardized regimen in Iran...
  37. ncbi Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection
    Davood Mansouri
    Division of Infectious Diseases and Clinical Immunology, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Darabad, Tehran, Iran
    Eur J Pediatr 164:753-7. 2005
    ....
  38. ncbi Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients
    Farah Dokht Fateminasab
    Department of Immunology, Iran University of Medical Sciences, Tehran, Iran
    Arch Iran Med 9:53-7. 2006
    ..tuberculosis replication. Alterations in cytolytic function, inappropriate maturation/differentiation, and limited proliferation could reduce their ability to control M.tuberculosis replication...
  39. doi Serum copper (cu) alterations in pulmonary tuberculosis patients under treatment with ethambutol
    Mohammad Abbasi Nazari
    Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University, Tehran, Iran
    Biol Trace Elem Res 128:161-6. 2009
    ..Our findings endorse the chelating effect of ethambutol leading to a decrease in serum levels of cationic trace elements, e.g., Cu...
  40. ncbi Chronic granulomatous disease with unusual clinical manifestation, outcome, and pattern of inheritance in an Iranian family
    Saeed F Tafti
    National Research Institute for Tuberculosis and Lung Diseases, Masih Daneshvary Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
    J Clin Immunol 26:291-6. 2006
    ..The parents are healthy. Our report describes the clinical manifestations and outcome in this family. The inheritance pattern suggests an autosomal recessive pattern with high penetrance...
  41. doi Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy
    Ali Akbar Velayati
    Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease NRITLD, WHO Collaborating Centre, Shahid Beheshti University, Tehran, Iran
    Chemotherapy 55:303-7. 2009
    ..001). Information provided in this study is of significant importance in terms of drug selection for effective treatment of resistant strains...
  42. ncbi Do mitochondrial DNA haplogroups play a role in susceptibility to tuberculosis?
    Massoud Houshmand
    National Institute for Genetic Engineering and Biotechnology, Tehran, Iran
    Respirology 12:823-7. 2007
    ..This study aimed to determine whether the frequency of different mitochondrial haplogroups was significantly different in patients with tuberculosis (TB) compared with a normal population...
  43. ncbi Primary immune deficiencies presenting in adults: seven years of experience from Iran
    Davood Mansouri
    National Research Institute for Tuberculosis and Lung Diseases, Masih Daneshvary Hospital, Shahid Beheshti University of Medical Sciences, Darabad, Tehran, Iran
    J Clin Immunol 25:385-91. 2005
    ..Using the experience gained from these patients, we outline key "warning signs" suggestive of an underlying PID. Only through increased physician awareness will patients with PIDs receive timely diagnosis and optimal management...
  44. ncbi Differences in characteristics between Afghani and Iranian patients with pulmonary tuberculosis
    Mehdi Seyed Mirsaeidi
    Int J Infect Dis 11:180-2. 2007
  45. ncbi A long delay from the first symptom to definite diagnosis of pulmonary tuberculosis
    Seyed Mahdi Mirsaeidi
    Department of Pediatrics, Research Institute, Kosair Children s Hospital, University of Louisville, Louisville, USA
    Arch Iran Med 10:190-3. 2007
    ..Delay in the diagnosis may result in further mortality and morbidity. Because of the importance of delay in the diagnosis, we decided to study and evaluate the patient delay and physician delay...